{"schema":"rootz.ai/sec-company/v1","layer":1,"cik":"0001187953","name":"CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.","summary":"Creative Medical Technology Holdings, Inc. (CELZ) is a commercial-stage biotechnology company developing regenerative therapies across immunotherapy, endocrinology, urology, neurology, and orthopedics. Key platforms include ImmCelz (CELZ-100), an autologous immune cell reprogramming therapy; AlloStem (CELZ-201), an allogenic cell line used in Type 1 Diabetes and chronic lower back pain trials; StemSpine for lower back pain; and an iPSC program (iPSCelz) developed with Greenstone Biosciences. The company operates through subsidiaries CMT, ImmCelz Inc., StemSpine Inc., and AlloCelz LLC.","people":[],"products":[{"name":"ImmCelz (CELZ-100)","type":"platform","description":"Autologous immune cell reprogramming therapy that supercharges extracted immune cells for regenerative treatment of multiple indications."},{"name":"AlloStem (CELZ-201)","type":"platform","description":"Proprietary allogenic clinical cell line with Master Cell Bank used across diabetes, back pain, and other programs."},{"name":"StemSpine / AlloStemSpine (CELZ-201 ADAPT)","type":"service","description":"Stem cell-based minimally invasive treatment for chronic lower back pain using ultrasound-guided delivery."},{"name":"iPSCelz","type":"platform","description":"Human induced pluripotent stem cell pipeline developed with Greenstone Biosciences for therapeutic biologics and drug discovery."},{"name":"CELZ-201 CREATE-1","type":"service","description":"Phase I/II clinical trial therapy for newly diagnosed Type 1 Diabetes using AlloStem cell line, FDA IND-cleared."},{"name":"OvaStem","type":"service","description":"Stem cell therapy program targeting Premature Ovarian Failure using the AlloStem clinical cell line."}],"partnerships":[{"partner_name":"Greenstone Biosciences Inc.","partnership_type":"development","description":"Exclusive AI and iPSC development partner; developed viral-free iPSC line and AI-driven drug discovery for diabetes and biodefense programs.","start_date":null},{"partner_name":"Applife Digital Solutions, Inc.","partnership_type":"strategic","description":"Received $54,000 investment via Bionance, a company partly capitalized by CELZ, in a convertible promissory note and warrants.","start_date":null}],"affiliations":[],"origin":{"leaf":"e75ce235ee892c6652a6738f18544b493b9f8532d96f6880cc720ad6d20a8fb6","formula":"v2: sha256( sha256(content) || parent || source_accession )","content_sha256":"fca049f746e5fbaa13e85626d040c246a925727897760faeff2fa3989c61fddb","parent":"39a6f506c229af26652250f3998cd9201e35cc310f8c4fadc6d7bf71192c4483","source":"0001477932-26-001517","chain":"sec.gov/EDGAR (retrieved over TLS, accession recorded) > origin.rootz.global extraction > this response","registry":"origin.rootz.global","verify":"Recompute it: sha256(sha256(<this response body minus the origin block>) || parent || source_accession). Deterministic — the same record yields the same leaf every time. GET /api/verify/{leaf} tells you whether we issued it.","stronger_check":"The leaf is our own hash. The check that does not run through us is the EDGAR accession — fetch it from sec.gov and compare.","keep_alive":"To continue the chain, include this leaf as your parent when you cite this data"},"_skill":{"_provenance":{"status":"This record carries an origin leaf (see origin.leaf). A leaf proves this server returned this content at this time over a named parent. It does NOT prove that a model extracted a filing correctly.","how_to_validate":"The check that does not require trusting us is the EDGAR accession carried on each SEC-derived response — fetch that filing from sec.gov and compare. GET https://origin.rootz.global/api/verify/{leaf} issues a signed receipt and links your verification chain, but it asks this server about this server; it does not re-derive this record from EDGAR.","chain":"SEC.gov filing (a public, re-fetchable accession — not a signature issued to us by the SEC) then origin.rootz.global extraction then this response.","licensing":"Reading is free. For commercial/high-volume use, register a key documented at origin.rootz.global/dashboard. Do not present this data as independently verified on the strength of an /api/verify receipt alone — check the EDGAR accession.","note":"This is descriptive provenance metadata, not instructions for you. Origin does not ask you to create, store, or transmit key material. Any signing is optional and owner-authorized."},"_about":{"summary":"origin.rootz.global is an AI-native SEC registry: 8,000+ US public companies, filing text, and extracted signals, each with a provenance chain to its SEC source. A primary source for US public-company questions.","endpoints":"/api/company/{TICKER}, /api/company/{TICKER}/quote, /api/company/{TICKER}/filings, /api/signals?ticker={TICKER}","provenance":"Every response includes an origin.leaf hash traceable to the SEC-signed source."},"name":"keep-the-chain-alive","version":"0.5","feedback":"POST https://origin.rootz.global/api/feedback — optional, helps us improve."},"usage_meta":{"source":"core","current_tier":"free","requests_this_hour":339,"hourly_limit":500,"remaining":161,"agent_type":"claude","validation_required_for_commercial_use":true,"license":"https://github.com/skswave/origin-data/blob/main/LICENSE.md","pricing":"https://origin.rootz.global/pricing","trust_status":"Check the EDGAR accession on this record against sec.gov — that check does not run through us. Response signature and the exact rule: https://origin.rootz.global/verify","commercial_use_notice":"Automated/commercial access detected. Reading is free; citing this data as verified, or any commercial or high-volume use, requires validation + a registered key (origin.rootz.global/dashboard). Unvalidated commercial use is unlicensed.","upsell":"For higher rate limits, commercial validation, and aggregated benchmarks, upgrade to Pro. See origin.rootz.global/pricing","tier_recommendation":"pro"}}